Walleye Capital’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-77,140
Closed -$6K 4009
2022
Q3
$6K Sell
77,140
-294
-0.4% -$30 ﹤0.01% 2918
2022
Q2
$7K Hold
77,434
﹤0.01% 2082
2022
Q1
$27K Buy
77,434
+2,850
+4% +$1.04K ﹤0.01% 1913
2021
Q4
$39K Buy
+74,584
New +$42.5K ﹤0.01% 1814

Other funds holding EQHA.WS

Walleye Capital's EQHA.WS Position: Q4 2022 in Review

Walleye Capital sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 77,140 shares — an estimated $6K sold.

Walleye Capital first reported a position in EQHA.WS in Q4 2021 and held it in 4 quarters. The position peaked at $39K in Q4 2021. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

  • Walleye Capital reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • Walleye Capital sold 77,140 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $6K.
  • Walleye Capital first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 4 quarters.
  • Walleye Capital's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $39K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.